share_log

Wells Fargo Maintains Overweight on Ironwood Pharmaceuticals, Lowers Price Target to $14

Moomoo 24/7 ·  Mar 1 13:00

Wells Fargo analyst Mohit Bansal maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Overweight and lowers the price target from $20 to $14.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment